Abstract
Background: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document. Methods: ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. Results: ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided. Conclusion: This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS.
Original language | English |
---|---|
Pages (from-to) | 213-739 |
Number of pages | 527 |
Journal | International Forum of Allergy and Rhinology |
Volume | 11 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2021 |
Keywords
- acute rhinosinusitis
- chronic rhinosinusitis
- endoscopic sinus surgery
- evidence-based medicine
- recurrent acute rhinosinusitis
- rhinosinusitis
- systematic review